Derma Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Derma Sciences's estimated annual revenue is currently $75M per year.
- Derma Sciences's estimated revenue per employee is $721,154
- Derma Sciences's total funding is $29.1M.
Employee Data
- Derma Sciences has 104 Employees.
- Derma Sciences grew their employee count by 1% last year.
Derma Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Business Systems Analyst | Reveal Email/Phone |
2 | Senior CSR / Marketing Coordinator | Reveal Email/Phone |
Derma Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.8M | 31 | 11% | N/A | N/A |
#2 | $12.3M | 49 | -4% | N/A | N/A |
#3 | $15.1M | 60 | 7% | N/A | N/A |
#4 | $8.8M | 35 | -8% | N/A | N/A |
#5 | $3M | 12 | 9% | N/A | N/A |
#6 | $300.4M | 1197 | 3% | N/A | N/A |
#7 | $311.7M | 1242 | 2% | N/A | N/A |
#8 | $0.3M | 1 | -96% | N/A | N/A |
#9 | $8.3M | 33 | 3% | N/A | N/A |
#10 | $13.6M | 54 | 8% | N/A | N/A |
What Is Derma Sciences?
Derma Sciences, Inc. provides a full range of skin care, wound management, and specialty securement devices that are used primarily in the professional markets, specifically - hospitals, nursing homes and home care settings. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.
keywords:N/A$29.1M
Total Funding
104
Number of Employees
$75M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Derma Sciences News
Derma Sciences; Fziomed; Alliqua Biomedical; Skye Biologics; Iop Ophthalmics Amniotic Membranes Market Breakdown by Type: Cryopreservation Of Amniotic...
... Outlook And Forecast | Johnson & Johnson, 3M, Medtronic, Dynarex, Smith & Nephew, BDF, Hartmann, Kawamoto, Medline, Derma Sciences.
Derma Sciences; Cardinal Health; Advanced Tissue; HARTMANN; RegenQuest; Lantor; SealSkin Medical Wrap; Wacker Chemie; Medline Industries.
The move will help bring in more revenue for the company, which increased losses in 2011 to $4.3 million compared with $2.4 million in 2010, according to its fourth-quarter earnings published today. Earlier this month, Derma Sciences’ treatment for diabetic foot ulcers, DSC127, achieved positiv ...
The Princeton, New Jersey-based company, citing data from Susquehanna Research, said diabetic foot ulcers affect 900,000 people annually in the United States. The company estimates the value of the diabetic foot ulcer treatment market at $3 billion. Edward J. Quilty, CEO of Derma Sciences, said ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 106 | 6% | N/A |
#2 | $15.4M | 106 | 9% | N/A |
#3 | $15.5M | 107 | 4% | N/A |
#4 | $15.5M | 107 | 3% | N/A |
#5 | $15.7M | 108 | N/A | N/A |